- Anti-Blood Group Antibodies in Intravenous Immunoglobulin May Complicate Interpretation of Antibody Titers in ABO-Incompatible TransplantationStaley EM, Carruba SS, Manning M, Pham HP, Williams LA 3rd, Marques MB, Locke JE, Lorenz RG. Am J Transplant. 2016 Aug;16(8):2483-6
- Inpatient Mortality Among Solid Organ Transplant Recipients Hospitalized for Sepsis and Severe SepsisDonnelly JP, Locke JE, MacLennan PA, McGwin G Jr, Mannon RB, Safford MM, Baddley JW, Muntner P, Wang HE. Clin Infect Dis. 2016 Jul 15;63(2):186-94.
- Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected RecipientsLocke JE, Durand C, Reed RD, MacLennan PA, Mehta S, Massie A, Nellore A, DuBay D, Segev DL. Transplantation. 2016 Jan;100(1):141-6
- Hospital-onset Clostridium difficile infection among solid organ transplant recipientsDonnelly JP, Wang HE, Locke JE, Mannon RB, Safford MM, Baddley JW. Am J Transplant. 2015 Nov;15(11):2970-7.
- Center-Level Experience and Kidney Transplant Outcomes in HIV-Infected RecipientsLocke JE, Reed RD, Mehta SG, Durand C, Mannon RB, MacLennan P, Shelton B, Martin MY, Qu H, Shewchuk R, Segev DL. Am J Transplant. 2015 Aug;15(8):2096-104
- A National Study of Outcomes among HIV-Infected Kidney Transplant RecipientsLocke JE, Mehta S, Reed RD, MacLennan P, Massie A, Nellore A, Durand C, Segev DL. J Am Soc Nephrol. 2015 Sep;26(9):2222-9.
- Identification of strategies to facilitate organ donation among African Americans using the nominal group techniqueLocke JE, Qu H, Shewchuk R, Mannon RB, Gaston R, Segev DL, Mannon EC, Martin MY. Clin J Am Soc Nephrol. 2015 Feb 6;10(2):286-93.
- The impact of proposed changes in liver allocation policy on cold ischemia times and organ transportation costsDuBay DA, MacLennan PA, Reed RD, Fouad M, Martin M, Meeks CB, Taylor G, Kilgore ML, Tankersley M, Gray SH, White JA, Eckhoff DE, Locke JE. Am J Transplant. 2015 Feb;15(2):541-6
- Eculizumab and splenectomy as salvage therapy for severe antibody-mediated rejection after HLA-incompatible kidney transplantationOrandi BJ, Zachary AA, Dagher NN, Bagnasco SM, Garonzik-Wang JM, Van Arendonk KJ, Gupta N, Lonze BE, Alachkar N, Kraus ES, Desai NM, Locke JE, Racusen LC, Segev DL, Montgomery RA. Transplantation. 2014 Oct 27;98(8):857-63.
- To whom goes the kidney?Locke JE. Liver Transpl. 2014 Sep;20(9):1017-8
- The authors’ reply.Locke JE, Segev DL. Transplantation. 2014 Jun 27;97(12):e70-1.
- Resource utilization associated with procurement of transplantable organs from donors that do not meet OPTN eligible death criteriaDuBay DA, Redden DT, Bryant MK, Dorn DP, Fouad MN, Gray SH, White JA, Locke JE, Meeks CB, Taylor GC, Kilgore ML, Eckhoff DE. Transplantation. 2014 May 27;97(10):1043-8
- Is there a role for detection of complement-binding antibodies in kidney transplantation?Locke JE, Segev DL. Am J Kidney Dis. 2014 Apr;63(4):558-60.
- Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipientsLocke JE, James NT, Mannon RB, Mehta SG, Pappas PG, Baddley JW, Desai NM, Montgomery RA, Segev DL. Transplantation. 2014 Feb 27;97(4):446-50.
- Donor-derived organ transplant transmission of coccidioidomycosisDierberg KL, Marr KA, Subramanian A, Nace H, Desai N, Locke JE, Zhang S, Diaz J, Chamberlain C, Neofytos D. Transpl Infect Dis. 2012 Jun;14(3):300-4
- In vitro and ex vivo delivery of short hairpin RNAs for control of hepatitis C viral transcript expressionLonze BE, Holzer HT, Knabel MK, Locke JE, DiCamillo GA, Karhadkar SS, Montgomery RA, Sun Z, Warren DS, Cameron AM. Arch Surg. 2012 Apr;147(4):384-7.
- Outcomes of renal transplants from Centers for Disease Control and Prevention high-risk donors with prospective recipient viral testing: a single-center experienceLonze BE, Dagher NN, Liu M, Kucirka LM, Simpkins CE, Locke JE, Desai NM, Cameron AM, Montgomery RA, Segev DL, Singer AL. Arch Surg. 2011 Nov;146(11):1261-6
- Late graft loss among pediatric recipients of DCD kidneysVan Arendonk KJ, James NT, Locke JE, Montgomery RA, Colombani PM, Segev DL. Clin J Am Soc Nephrol. 2011 Nov;6(11):2705-11
- Desensitization in HLA-incompatible kidney recipients and survivalMontgomery RA, Lonze BE, King KE, Kraus ES, Kucirka LM, Locke JE, Warren DS, Simpkins CE, Dagher NN, Singer AL, Zachary AA, Segev DL. N Engl J Med. 2011 Jul 28;365(4):318-26
- Evolving concepts in the selection of immunosuppression regimen for liver transplant recipientsLocke JE, Singer AL. Hepat Med. 2011 May 13;3:53-62
- Login
- |
- Privacy
- |
- Terms of Use
- |
- © 2024 The University of Alabama at Birmingham
UAB is an Equal Employment/Equal Educational Opportunity Institution dedicated to providing equal opportunities and equal access to all individuals regardless of race, color, religion, ethnic or national origin, sex (including pregnancy), genetic information, age, disability, religion, sexual orientation, gender identity, gender expression, and veteran’s status. As required by Title IX, UAB prohibits sex discrimination in any education program or activity that it operates. Individuals may report concerns or questions to UAB’s Assistant Vice President and Senior Title IX Coordinator. The Title IX notice of nondiscrimination is located at uab.edu/titleix.